T Man Pharmaceutical PCL
T.Man Pharmaceutical Public Company Limited manufactures and sells pharmaceuticals and health care products in Thailand. The company operates through three segments: Manufactured Products Under Own Brand, Manufactured Products Under Third Parties' Brand, and Trading Products. It offers antibacterial, central nervous system, corticosteroid, chronic diseases, gastrointestinal, respiratory, and musc… Read more
T Man Pharmaceutical PCL (TMAN) - Net Assets
Latest net assets as of : ฿- THB
Based on the latest financial reports, T Man Pharmaceutical PCL (TMAN) has net assets worth ฿- THB as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (฿-) and total liabilities (฿-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ฿- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
T Man Pharmaceutical PCL - Net Assets Trend (None–None)
This chart illustrates how T Man Pharmaceutical PCL's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for T Man Pharmaceutical PCL (None–None)
The table below shows the annual net assets of T Man Pharmaceutical PCL from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to T Man Pharmaceutical PCL's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
T Man Pharmaceutical PCL Competitors by Market Cap
The table below lists competitors of T Man Pharmaceutical PCL ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Samaiden Group Bhd
KLSE:0223
|
$28.20 Million |
|
Navamedic ASA
OL:NAVA
|
$28.20 Million |
|
Walkabout Resources Ltd
AU:WKT
|
$28.23 Million |
|
Spir Group ASA
OL:SPIR
|
$28.24 Million |
|
Inversiones Doalca SOCIMI SA
MC:YDOA
|
$28.20 Million |
|
Paratech Company Limited
KQ:033540
|
$28.19 Million |
|
Texas Rare Earth Resources Corp
OTCQB:TMRC
|
$28.19 Million |
|
Arctic Gold Publ AB
ST:ARCT
|
$28.17 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in T Man Pharmaceutical PCL's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares T Man Pharmaceutical PCL's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently T Man Pharmaceutical PCL utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares T Man Pharmaceutical PCL's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $417,259,109
- Average return on equity (ROE) among peers: -167.11%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| T Man Pharmaceutical PCL (TMAN) | ฿- | N/A | N/A | $28.20 Million |
| Eternal Energy Public Company Limited (EE) | $144.95 Million | 37.64% | 2.56x | $10.10 Million |
| Mega Lifesciences Public Company Limited (MEGA-R) | $849.90 Million | 0.00% | 1.61x | $320.06 Million |
| Techlead NPN Public Company Limited (TL) | $256.93 Million | -538.97% | 0.06x | $19.34 Million |